OSUR News and Press, OraSure Technologies Inc. From 07/14/22

BETHLEHEM, Pa., July 14, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that its OMNIgene ® •GUT DNA and RNA product ( OMR-205 ) is now a...

OraSure has pushed lower on the charts in recent times amid a series of headwinds. Qualitatively there are potential upside catalysts yet to be realized by the stock, however, these look to be well priced in already. Fundamentals have softened in recent years and offer a small por...

BETHLEHEM, Pa., June 08, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that on June 4, 2022, OraSure’s Board of Directors granted Carrie Eglinton Man...

OraSure Technologies (NASDAQ:OSUR) is trading higher in the pre-market Wednesday after the diagnostic test maker said that the U.S. Department of Health and Human Services (HHS) had selected its InteliSwab COVID-19 Rapid Test for distributions across the nation’s schools. Tests sent to...

BETHLEHEM, Pa., May 25, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that its InteliSwab ® COVID-19 Rapid Test has been selected by the U.S. Depar...

OraSure Technologies (NASDAQ:OSUR) announces that Carrie Eglinton Manner has been appointed President and CEO, effective June 4, 2022.  Ms. Eglinton Manner will also join the Board of Directors. She succeeds Dr. Nancy Gagliano, who was appointed interim CEO ...

BETHLEHEM, Pa., May 23, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, today announced that Carrie Eglinton Manner has been appointed President and Chief Executive Officer, ...

BETHLEHEM, Pa., May 17, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that its InteliSwab ® COVID-19 rapid tests detect the Omicron BA.2, BA.2.12.1...

OraSure Technologies, Inc. (OSUR) Q1 2022 Earnings Conference Call May 10, 2022 17:00 ET Company Participants Kathleen Weber - President of Molecular Solutions Lisa Nibauer - President of Diagnostics Nancy Gagliano - Interim Chief Executive Officer & Director Scott Gleason - Senior Vice P...

OraSure Technologies press release (NASDAQ:OSUR): Q1 GAAP EPS of -$0.28. Revenue of $67.71M (+15.6% Y/Y). Shares -1%. For further details see: OraSure Technologies GAAP EPS of -$0.28, revenue of $67.71M